ipilimumab,nivolumab,cabozantinib
exelixis,bms
['nivo', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'gusm', 'cabozantinib', 'rcc,(-irccs),(-srcc),(-urcc)', 'cosmic-313']
cosmic-313: adding cabozantinib to nivo-ipi prolonged pfs in rcc. results presented at #esmo22 by . #rccsm #gusm 
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.